Cor Vasa 2023, 65(3):461-467 | DOI: 10.33678/cor.2022.095

The impact of the cardiovascular risk factors on short-term in-hospital outcome of patients with COVID-19

Noha Hassanin Hanboly, Sameh Wadie, Reda Hussain Diab, Mohamed Omar
Cardiovascular Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Background: Coronavirus disease (COVID-19) has caused significant morbidity and mortality. COVID-19 is more than a respiratory illness, it had multiple systemic effects such as myocarditis, arrhythmias, and venous thromboembolism. Aim of the study: We aimed to study the frequency of cardiovascular risk factors in patients with COVID-19 and the impact of these risk factors on short-term in-hospital outcome of patients newly discovered with COVID-19.

Materials and methods: Cross-sectional analytic study conducted in Egypt on 200 patients (mean age of 44.2±12.7 years old) with positive polymerase chain reaction for COVID-19 recruited from different isolation hospitals. Patients were subjected to history taking, physical examination, and cardiac examination. The cardiovascular risk profile was studied among the enrolled patients. Twelve-lead electrocardiogram, routine laboratory tests, and computed tomography chest study were done for all patients. Patients were grouped into two groups A and B for survivors and non-survivors, respectively. Data were entered using the statistical package for social sciences, version 20.0 (SPSS Inc., Chicago, Illinois, USA).

Results: The study was conducted on two hundred patients aged 20 to 79 years with male predominance. The study found that 181 patients (90.5%) survived (Group A) and 19 patients (9.5%) died (Group B). Multivariate analysis revealed that significant predictors of death were age above 60 years old, systemic hypertension, diabetes mellitus, obesity and dyslipidemia.

Conclusions: Systemic hypertension, diabetes mellitus, obesity, and dyslipidemia were more prevalent in non-survivor patients with COVID-19.

Keywords: COVID-19, Diabetes mellitus, Systemic hypertension,

Received: July 27, 2022; Revised: July 27, 2022; Accepted: August 22, 2022; Published: June 20, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hassanin Hanboly N, Wadie S, Diab RH, Omar M. The impact of the cardiovascular risk factors on short-term in-hospital outcome of patients with COVID-19. Cor Vasa. 2023;65(3):461-467. doi: 10.33678/cor.2022.095.
Download citation

References

  1. Shereen MA, Khan S, Kazmi A, et al. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res 2020;24:91-98. Go to original source... Go to PubMed...
  2. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019;17:181-192. Go to original source... Go to PubMed...
  3. Lai CC, Shih TP, Ko WC, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020;55:105924. Go to original source... Go to PubMed...
  4. Organization WHO. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020. World Health Organization 2020.
  5. Walensky RP, Walke HT, Fauci AS. SARS-CoV-2 Variants of Concern in the United States - Challenges and Opportunities. JAMA 2021;325:1037-1038. Go to original source...
  6. Davies NG, Jarvis CI; CMMID COVID-19 Working Group, et al. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7. Nature 2021;593:270-274. Go to original source...
  7. Tegally H, Wilkinson E, Giovanetti M, et al. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature 2021;592:438-443. Go to original source... Go to PubMed...
  8. Faria NR, Mellan TA, Whittaker C, et al. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science 2021;372:815-821. Go to original source...
  9. Vaughan A. Omicron emerges. New Sci 2021;252:7. Go to original source...
  10. Chen J, Wang R, Gilby NB, Wei GW. Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance. J Chem Inf Model 2022;62:412-422. Go to original source... Go to PubMed...
  11. Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill 2020;25:2000062. Go to original source...
  12. Struyf T, Deeks JJ, Dinnes J, et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Cochrane Database Syst Rev 2021;2:CD013665. Go to original source... Go to PubMed...
  13. Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and Multiorgan Response. Curr Probl Cardiol 2020;45:100618. Go to original source...
  14. Tavakolpour S, Rakhshandehroo T, Wei EX, Rashidian M. Lymphopenia during the COVID-19 infection: What it shows and what can be learned. Immunol Lett 2020;225:31-32. Go to original source... Go to PubMed...
  15. Hefeda MM. CT chest findings in patients infected with COVID-19: review of literature. Egypt J Radiol Nucl Med 2020;51:239. Go to original source...
  16. Torretta S, Zuccotti G, Cristofaro V, et al. Diagnosis of SARS-CoV-2 by RT-PCR Using Different Sample Sources: Review of the Literature. Ear Nose Throat J 2021;100:131S-138S. Go to original source... Go to PubMed...
  17. Clerici B, Muscatello A, Bai F, et al. Sensitivity of SARS-CoV-2 Detection with Nasopharyngeal Swabs. Front Public Health 2021;8:593491. Go to original source...
  18. Siripanthong B, Nazarian S, Muser D, et al. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm 2020;17:1463-1471. Go to original source... Go to PubMed...
  19. Graves DT, Kayal RA. Diabetic complications and dysregulated innate immunity. Front Biosci 2008;13:1227-1239. Go to original source...
  20. Sen S, Chakraborty R, Kalita P, Pathak MP. Diabetes mellitus and COVID-19: Understanding the association in light of current evidence. World J Clin Cases 2021;9:8327-8339. Go to original source...
  21. Mackey K, King VJ, Gurley S, et al. Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults: A Living Systematic Review. Ann Intern Med 2020;173:195-203. Go to original source... Go to PubMed...
  22. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020;323:2052-2059. Go to original source...
  23. Wei ZY, Qiao R, Chen J, et al. The influence of pre-existing hypertension on coronavirus disease 2019 patients. Epidemiol Infect 2021;149:e4. Go to original source... Go to PubMed...
  24. Albashir AAD. The potential impacts of obesity on COVID-19. Clin Med (Lond) 2020;20:e109-e113. Go to original source...
  25. Sharifi Y, Payab M, Mohammadi-Vajari E, et al. Association between cardiometabolic risk factors and COVID-19 susceptibility, severity and mortality: a review. J Diabetes Metab Disord 2021;20:1743-1765. Go to original source... Go to PubMed...
  26. Bergler-Klein J. What's new in the ESC 2018 guidelines for arterial hypertension: The ten most important messages. Wien Klin Wochenschr 2019;131:180-185. Go to original source... Go to PubMed...
  27. Florkowski C. HbA1c as a Diagnostic Test for Diabetes Mellitus - Reviewing the Evidence. Clin Biochem Rev 2013;34:75-83. Go to PubMed...
  28. Ahmed SM, Clasen ME, Donnelly JE. Management of dyslipidemia in adults. Am Fam Physician 1998;57:2192-2204, 2207-2208. Go to original source...
  29. Freedman DS, Horlick M, Berenson GS. A comparison of the Slaughter skinfold-thickness equations and BMI in predicting body fatness and cardiovascular disease risk factor levels in children. Am J Clin Nutr 2013;98:1417-1424. Go to original source... Go to PubMed...
  30. Popat B, Jones AT. Invasive and non-invasive mechanical ventilation. Medicine (Abingdon) 2012;40:298-304. Go to original source... Go to PubMed...
  31. Walter JM, Corbridge TC, Singer BD. Invasive Mechanical Ventilation. South Med J 2018;111:746-753. Go to original source... Go to PubMed...
  32. Kapitan KS. Ventilatory failure. Can you sustain what you need? Ann Am Thorac Soc 2013;10:396-399. Go to original source... Go to PubMed...
  33. Brown LK, Javaheri S. Positive Airway Pressure Device Technology Past and Present: What's in the "Black Box"? Sleep Med Clin 2017;12:501-515. Go to original source... Go to PubMed...
  34. Nicholson CJ, Wooster L, Sigurslid HH, et al. Estimating risk of mechanical ventilation and in-hospital mortality among adult COVID-19 patients admitted to Mass General Brigham: The VICE and DICE scores. EClinicalMedicine 2021;33:100765. Go to original source... Go to PubMed...
  35. Polimeni A, Leo I, Spaccarotella C, et al. Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients. Sci Rep 2021;11:10464. Go to original source... Go to PubMed...
  36. Pareek M, Singh A, Vadlamani L, et al. Relation of Cardiovascular Risk Factors to Mortality and Cardiovascular Events in Hospitalized Patients With Coronavirus Disease 2019 (from the Yale COVID-19 Cardiovascular Registry). Am J Cardiol 2021;146:99-106. Go to original source... Go to PubMed...
  37. Fried JA, Ramasubbu K, Bhatt R, et al. The variety of cardiovascular presentations of COVID-19. Circulation 2020;141:1930-1936. Go to original source... Go to PubMed...
  38. Collard D, Nurmohamed NS, Kaiser Y, et al. Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort study. BMJ Open 2021;11:e045482. Go to original source... Go to PubMed...
  39. Patel U, Malik P, Usman MS, et al. Age-Adjusted Risk Factors Associated with Mortality and Mechanical Ventilation Utilization amongst COVID-19 Hospitalizations - a Systematic Review and Meta-Analysis. SN comprehensive clinical medicine 2020;2:1740-1749. Go to original source... Go to PubMed...
  40. Gamberini L, Tonetti T, Spadaro S, et al. Factors influencing liberation from mechanical ventilation in coronavirus disease 2019: multicenter observational study in fifteen Italian ICUs. J Intensive Care 2020;8:80. Go to original source...
  41. de Oliveira Lima H, da Silva LM, de Campos Vieira Abib A, et al. Coronavirus disease-related in-hospital mortality: a cohort study in a private healthcare network in Brazil. Sci Rep 2022;12:6371. Go to original source... Go to PubMed...
  42. Jewbali LSD, Hoogervorst-Schilp J, Belfroid E, et al. Impact of cardiovascular disease and cardiovascular risk factors in hospitalised COVID-19 patients. Neth Heart J 2021;29:13-19. Go to original source...
  43. Soeroto AY, Soetedjo NN, Purwiga A, et al. Effect of increased BMI and obesity on the outcome of COVID-19 adult patients: A systematic review and meta-analysis. Diabetes Metab Syndr 2020;14:1897-1904. Go to original source...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.